Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nanobiotix wins patent for nanoXray anticancer platform
According to the company, the patent protects composite particles that can generate free radicals or heat when excited by X-rays, and to the uses thereof in health, particularly
According to the company, the patent protects composite particles that can generate free radicals or heat when excited by X-rays, and to the uses thereof in health, particularly
The court found that administration of Enbrel falls outside the scope of the asserted claims based on the court’s interpretation of these claims to exclude extracellular methods of
This orphan medicinal product designation qualifies Tengion and its Neo-Bladder augment for European Medicines Agency (EMEA) regulatory incentives, including eligibility for protocol assistance and possible exemptions or reductions
AstraZeneca has been working with the FDA in the investigation of the safety and effectiveness of Casodex in a pediatric setting but will not be seeking an indication
The agreement leading to the improved offer was unanimously approved by the board of directors of Zentiva, and the board has recommended that Zentiva shareholders tender their shares
The Phase I, open-label, dose escalation study is evaluating the safety, tolerability, and pharmacokinetics of a single intravitreal injection of iCo-007 in patients with diffuse diabetic macular edema
CytRx has purchased Innovive for a total consideration of approximately 2.6 million shares of CytRx common stock, approximately $18.3 million of future performance-based milestone earn-outs, and the assumption
CryoLife has started distributing Hemostase MPH in the US, the UK and Germany in the second quarter of 2008. Distribution will continue to expand to additional markets later
This trial is expected to be the first of two pivotal Phase III trials required to support filing for regulatory approval for Gammagard Liquid as a potential treatment
The study, which will be used to support the filing with health authorities worldwide, includes more than 1,100 patients between 51 and 80 years old with a medical